research: Hopkins seeks participants for azacitidine and entinostat study

Johns Hopkins is currently seeking participants for a phase II clinical trial for treating patients with advanced breast cancer with azacitidine and entinostat. Several sites are participating in the US, Australia, China and Singapore. Be sure to click the link to learn more and share with your oncology team.

5 6 7 8
© 2004–2011 Donna Peach. All rights reserved.
Advertisements

One response to “research: Hopkins seeks participants for azacitidine and entinostat study

  1. Make sure to do some research on this one before making a decision. In a study on a different cancer, the combo turned out to be less effective than the Azacitidine/Vidaza alone (the Azacitidine also turned out to be more effective at a low dose than at a high dose, interestingly), and had much greater side effects. This study is doing the drugs on the suggested schedule that they posit may be more effective, but there is quite a bit to consider here. Start with:

    http://www.mdsbeacon.com/news/2011/01/07/extended-treatment-with-low-dose-vidaza-improves-response-rate-in-mds-patients-ash-2010/

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s